P5.4 Case Report: Donor-Derived Microsporidiosis Infection in a Pediatric Kidney Transplant Recipient
Dr. Katrina L. Epperson, United States
P5.5 Cancer prevalence and risk factors among Korean solid organ transplant recipients
Hee Gyung Kang, Korea
P5.6 Epstein Barr Virus risk stratification as a tool to predict post-transplant lymphoproliferative disorder in pediatric liver transplant recipients
Dr. Priya Walabh, South Africa
P5.7 EBV (Epstein Barr Virus) driven post-transplant lymphoproliferative disease (PTLD) – a pediatric disease in the adult transplant patient: A single case study using evidence-based practice to improve the transition of care
Mrs. Katherine G. Robinson, United States
P5.8 Current status of pediatric solid organ transplantation in Japan: Disease transmission surveillance in the country where living-donor transplantation is dominant
Dr. Masaki Yamada, Japan
P5.9 A case of native kidney post-transplant lymphoproliferative disorder and BK nephropathy after orthotopic heart transplantation
Yitong A. Liu, United States
P5.10 Ampicillin rash does not occur among pediatric liver transplant recipients even in the presence of EBV DNAemia
Dr. Yusuke Tokuda, Japan
P5.11 A case of cytomegalovirus-related hemorrhagic cystitis early after pediatric kidney transplantation
Prof. Longshan Liu, People's Republic of China
P5.13 BK viruria in pediatric heart transplant patients and its correlation with kidney function-A Single center retrospective study